Mixed results with two stents for bifurcations
January 16, 2014|Hospitalist News (Archived)
Author and Disclosure Information
AT TCT 2013
Post hoc subset analyses suggested that the 41% of patients with larger side branches (more than 2.25 mm) showed greater benefit from the two-stent approach than did other patients.
Bifurcation lesions account for 15%-20% of all coronary lesions treated by percutaneous coronary intervention, Dr. Kumsars said.
Dr. Kumsars reported having no financial disclosures. Dr. Leon reported financial associations with Abbott, Boston Scientific, and Medtronic. Tryton Medical sponsored the TRYTON study.
On Twitter @sherryboschert
